Subcutaneous Drug Delivery Devices Market 2027 By Type, Technology, Distribution Channel and Geography | The Insight Partners

Subcutaneous Drug Delivery Devices Market to 2027 - Global Analysis and Forecasts by Type (Prefilled Injectable, Fillable Injectable); Technology (Syringes, Pens, Patches, Others); Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies), and Geography

Report Code: TIPRE00006411 | No. of Pages: 150 | Category: Medical Device | Status: Upcoming
MARKET INTRODUCTION

Subcutaneous delivery of the drug is a process of administering medication or medicine under the skin. In the subcutaneous drug delivery process, a small needle is used to inject the drug in the tissue present in between muscle and skin. The drug is injected in small amount, which varies between 1 mL to 2mL. For instance, insulin is widely administered through subcutaneous injection. The abdomen, arm, and thigh are the most common injection sites for subcutaneous injection.

MARKET DYNAMICS

The market for subcutaneous drug delivery devices is expected to grow during the forecast years due to the key factors such as rising prevalence of chronic diseases, high demand for minimally invasive drug delivery technology, and changing lifestyle. The market is expected to have several growth opportunities in the emerging nations where the market is estimated to adopt new technologies.

MARKET SCOPE

The "Global Subcutaneous Drug Delivery Devices Market Analysis to 2027" is a specialized and in-depth study of the medical device industry with a special focus on the global market trend analysis. The report aims to provide an overview of subcutaneous drug delivery devices market with detailed market segmentation by type, technology, distribution channel and geography. The global subcutaneous drug delivery devices market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading subcutaneous drug delivery devices market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The global subcutaneous drug delivery devices market is segmented on the basis of type, technology, distribution channel. Based on the type the market is segmented as prefilled injectable and fillable injectable. On the basis of technology the market is segmented as syringes, pens, patches and others. Further, based on the distribution channel the market is segmented as retail pharmacies, hospital pharmacies and online pharmacies.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global subcutaneous drug delivery devices market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The subcutaneous drug delivery devices market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting subcutaneous drug delivery devices market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the subcutaneous drug delivery devices market in these regions.

MARKET PLAYERS

The reports cover key developments in the subcutaneous drug delivery devices market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from subcutaneous drug delivery devices market are anticipated to have lucrative growth opportunities in the future with the rising demand for subcutaneous drug delivery devices in the global market. Below mentioned is the list of few companies engaged in the subcutaneous drug delivery devices market.

The report also includes the profiles of key subcutaneous drug delivery devices market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

- Insulet Corporation
- BD
- Enable Injections
- Consort Medical plc
- West Pharmaceutical Services, Inc
- Elcam Medical
- Amgen Inc
- Ypsomed AG
- scPharmaceuticals, Inc.
- Wilhelm Haselmeier GmbH and Co. KG

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Subcutaneous Drug Delivery Devices Market - By Type
1.3.2 Subcutaneous Drug Delivery Devices Market - By Technology
1.3.3 Subcutaneous Drug Delivery Devices Market - By Distribution Channel
1.3.4 Subcutaneous Drug Delivery Devices Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. SUBCUTANEOUS DRUG DELIVERY DEVICES MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. SUBCUTANEOUS DRUG DELIVERY DEVICES MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. SUBCUTANEOUS DRUG DELIVERY DEVICES MARKET - GLOBAL MARKET ANALYSIS
6.1. SUBCUTANEOUS DRUG DELIVERY DEVICES - GLOBAL MARKET OVERVIEW
6.2. SUBCUTANEOUS DRUG DELIVERY DEVICES - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. SUBCUTANEOUS DRUG DELIVERY DEVICES MARKET - REVENUE AND FORECASTS TO 2027 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. PREFILLED INJECTABLE
7.3.1. Overview
7.3.2. Prefilled Injectable Market Forecast and Analysis
7.4. FILLABLE INJECTABLE
7.4.1. Overview
7.4.2. Fillable Injectable Market Forecast and Analysis
8. SUBCUTANEOUS DRUG DELIVERY DEVICES MARKET - REVENUE AND FORECASTS TO 2027 - TECHNOLOGY
8.1. OVERVIEW
8.2. TECHNOLOGY MARKET FORECASTS AND ANALYSIS
8.3. SYRINGES
8.3.1. Overview
8.3.2. Syringes Market Forecast and Analysis
8.4. PENS
8.4.1. Overview
8.4.2. Pens Market Forecast and Analysis
8.5. PATCHES
8.5.1. Overview
8.5.2. Patches Market Forecast and Analysis
8.6. OTHERS
8.6.1. Overview
8.6.2. Others Market Forecast and Analysis
9. SUBCUTANEOUS DRUG DELIVERY DEVICES MARKET - REVENUE AND FORECASTS TO 2027 - DISTRIBUTION CHANNEL
9.1. OVERVIEW
9.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
9.3. RETAIL PHARMACIES
9.3.1. Overview
9.3.2. Retail Pharmacies Market Forecast and Analysis
9.4. HOSPITAL PHARMACIES
9.4.1. Overview
9.4.2. Hospital Pharmacies Market Forecast and Analysis
9.5. ONLINE PHARMACIES
9.5.1. Overview
9.5.2. Online Pharmacies Market Forecast and Analysis
10. SUBCUTANEOUS DRUG DELIVERY DEVICES MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Subcutaneous Drug Delivery Devices Market Overview
10.1.2 North America Subcutaneous Drug Delivery Devices Market Forecasts and Analysis
10.1.3 North America Subcutaneous Drug Delivery Devices Market Forecasts and Analysis - By Type
10.1.4 North America Subcutaneous Drug Delivery Devices Market Forecasts and Analysis - By Technology
10.1.5 North America Subcutaneous Drug Delivery Devices Market Forecasts and Analysis - By Distribution Channel
10.1.6 North America Subcutaneous Drug Delivery Devices Market Forecasts and Analysis - By Countries
10.1.6.1 United States Subcutaneous Drug Delivery Devices Market
10.1.6.1.1 United States Subcutaneous Drug Delivery Devices Market by Type
10.1.6.1.2 United States Subcutaneous Drug Delivery Devices Market by Technology
10.1.6.1.3 United States Subcutaneous Drug Delivery Devices Market by Distribution Channel
10.1.6.2 Canada Subcutaneous Drug Delivery Devices Market
10.1.6.2.1 Canada Subcutaneous Drug Delivery Devices Market by Type
10.1.6.2.2 Canada Subcutaneous Drug Delivery Devices Market by Technology
10.1.6.2.3 Canada Subcutaneous Drug Delivery Devices Market by Distribution Channel
10.1.6.3 Mexico Subcutaneous Drug Delivery Devices Market
10.1.6.3.1 Mexico Subcutaneous Drug Delivery Devices Market by Type
10.1.6.3.2 Mexico Subcutaneous Drug Delivery Devices Market by Technology
10.1.6.3.3 Mexico Subcutaneous Drug Delivery Devices Market by Distribution Channel
10.2. EUROPE
10.2.1 Europe Subcutaneous Drug Delivery Devices Market Overview
10.2.2 Europe Subcutaneous Drug Delivery Devices Market Forecasts and Analysis
10.2.3 Europe Subcutaneous Drug Delivery Devices Market Forecasts and Analysis - By Type
10.2.4 Europe Subcutaneous Drug Delivery Devices Market Forecasts and Analysis - By Technology
10.2.5 Europe Subcutaneous Drug Delivery Devices Market Forecasts and Analysis - By Distribution Channel
10.2.6 Europe Subcutaneous Drug Delivery Devices Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Subcutaneous Drug Delivery Devices Market
10.2.6.1.1 Germany Subcutaneous Drug Delivery Devices Market by Type
10.2.6.1.2 Germany Subcutaneous Drug Delivery Devices Market by Technology
10.2.6.1.3 Germany Subcutaneous Drug Delivery Devices Market by Distribution Channel
10.2.6.2 France Subcutaneous Drug Delivery Devices Market
10.2.6.2.1 France Subcutaneous Drug Delivery Devices Market by Type
10.2.6.2.2 France Subcutaneous Drug Delivery Devices Market by Technology
10.2.6.2.3 France Subcutaneous Drug Delivery Devices Market by Distribution Channel
10.2.6.3 Italy Subcutaneous Drug Delivery Devices Market
10.2.6.3.1 Italy Subcutaneous Drug Delivery Devices Market by Type
10.2.6.3.2 Italy Subcutaneous Drug Delivery Devices Market by Technology
10.2.6.3.3 Italy Subcutaneous Drug Delivery Devices Market by Distribution Channel
10.2.6.4 Spain Subcutaneous Drug Delivery Devices Market
10.2.6.4.1 Spain Subcutaneous Drug Delivery Devices Market by Type
10.2.6.4.2 Spain Subcutaneous Drug Delivery Devices Market by Technology
10.2.6.4.3 Spain Subcutaneous Drug Delivery Devices Market by Distribution Channel
10.2.6.5 United Kingdom Subcutaneous Drug Delivery Devices Market
10.2.6.5.1 United Kingdom Subcutaneous Drug Delivery Devices Market by Type
10.2.6.5.2 United Kingdom Subcutaneous Drug Delivery Devices Market by Technology
10.2.6.5.3 United Kingdom Subcutaneous Drug Delivery Devices Market by Distribution Channel
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Subcutaneous Drug Delivery Devices Market Overview
10.3.2 Asia-Pacific Subcutaneous Drug Delivery Devices Market Forecasts and Analysis
10.3.3 Asia-Pacific Subcutaneous Drug Delivery Devices Market Forecasts and Analysis - By Type
10.3.4 Asia-Pacific Subcutaneous Drug Delivery Devices Market Forecasts and Analysis - By Technology
10.3.5 Asia-Pacific Subcutaneous Drug Delivery Devices Market Forecasts and Analysis - By Distribution Channel
10.3.6 Asia-Pacific Subcutaneous Drug Delivery Devices Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Subcutaneous Drug Delivery Devices Market
10.3.6.1.1 Australia Subcutaneous Drug Delivery Devices Market by Type
10.3.6.1.2 Australia Subcutaneous Drug Delivery Devices Market by Technology
10.3.6.1.3 Australia Subcutaneous Drug Delivery Devices Market by Distribution Channel
10.3.6.2 China Subcutaneous Drug Delivery Devices Market
10.3.6.2.1 China Subcutaneous Drug Delivery Devices Market by Type
10.3.6.2.2 China Subcutaneous Drug Delivery Devices Market by Technology
10.3.6.2.3 China Subcutaneous Drug Delivery Devices Market by Distribution Channel
10.3.6.3 India Subcutaneous Drug Delivery Devices Market
10.3.6.3.1 India Subcutaneous Drug Delivery Devices Market by Type
10.3.6.3.2 India Subcutaneous Drug Delivery Devices Market by Technology
10.3.6.3.3 India Subcutaneous Drug Delivery Devices Market by Distribution Channel
10.3.6.4 Japan Subcutaneous Drug Delivery Devices Market
10.3.6.4.1 Japan Subcutaneous Drug Delivery Devices Market by Type
10.3.6.4.2 Japan Subcutaneous Drug Delivery Devices Market by Technology
10.3.6.4.3 Japan Subcutaneous Drug Delivery Devices Market by Distribution Channel
10.3.6.5 South Korea Subcutaneous Drug Delivery Devices Market
10.3.6.5.1 South Korea Subcutaneous Drug Delivery Devices Market by Type
10.3.6.5.2 South Korea Subcutaneous Drug Delivery Devices Market by Technology
10.3.6.5.3 South Korea Subcutaneous Drug Delivery Devices Market by Distribution Channel
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Subcutaneous Drug Delivery Devices Market Overview
10.4.2 Middle East and Africa Subcutaneous Drug Delivery Devices Market Forecasts and Analysis
10.4.3 Middle East and Africa Subcutaneous Drug Delivery Devices Market Forecasts and Analysis - By Type
10.4.4 Middle East and Africa Subcutaneous Drug Delivery Devices Market Forecasts and Analysis - By Technology
10.4.5 Middle East and Africa Subcutaneous Drug Delivery Devices Market Forecasts and Analysis - By Distribution Channel
10.4.6 Middle East and Africa Subcutaneous Drug Delivery Devices Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Subcutaneous Drug Delivery Devices Market
10.4.6.1.1 South Africa Subcutaneous Drug Delivery Devices Market by Type
10.4.6.1.2 South Africa Subcutaneous Drug Delivery Devices Market by Technology
10.4.6.1.3 South Africa Subcutaneous Drug Delivery Devices Market by Distribution Channel
10.4.6.2 Saudi Arabia Subcutaneous Drug Delivery Devices Market
10.4.6.2.1 Saudi Arabia Subcutaneous Drug Delivery Devices Market by Type
10.4.6.2.2 Saudi Arabia Subcutaneous Drug Delivery Devices Market by Technology
10.4.6.2.3 Saudi Arabia Subcutaneous Drug Delivery Devices Market by Distribution Channel
10.4.6.3 U.A.E Subcutaneous Drug Delivery Devices Market
10.4.6.3.1 U.A.E Subcutaneous Drug Delivery Devices Market by Type
10.4.6.3.2 U.A.E Subcutaneous Drug Delivery Devices Market by Technology
10.4.6.3.3 U.A.E Subcutaneous Drug Delivery Devices Market by Distribution Channel
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Subcutaneous Drug Delivery Devices Market Overview
10.5.2 South and Central America Subcutaneous Drug Delivery Devices Market Forecasts and Analysis
10.5.3 South and Central America Subcutaneous Drug Delivery Devices Market Forecasts and Analysis - By Type
10.5.4 South and Central America Subcutaneous Drug Delivery Devices Market Forecasts and Analysis - By Technology
10.5.5 South and Central America Subcutaneous Drug Delivery Devices Market Forecasts and Analysis - By Distribution Channel
10.5.6 South and Central America Subcutaneous Drug Delivery Devices Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Subcutaneous Drug Delivery Devices Market
10.5.6.1.1 Brazil Subcutaneous Drug Delivery Devices Market by Type
10.5.6.1.2 Brazil Subcutaneous Drug Delivery Devices Market by Technology
10.5.6.1.3 Brazil Subcutaneous Drug Delivery Devices Market by Distribution Channel
10.5.6.2 Argentina Subcutaneous Drug Delivery Devices Market
10.5.6.2.1 Argentina Subcutaneous Drug Delivery Devices Market by Type
10.5.6.2.2 Argentina Subcutaneous Drug Delivery Devices Market by Technology
10.5.6.2.3 Argentina Subcutaneous Drug Delivery Devices Market by Distribution Channel
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. SUBCUTANEOUS DRUG DELIVERY DEVICES MARKET, KEY COMPANY PROFILES
12.1. INSULET CORPORATION
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. BD
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. ENABLE INJECTIONS
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. CONSORT MEDICAL PLC
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. WEST PHARMACEUTICAL SERVICES, INC
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. ELCAM MEDICAL
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. AMGEN INC
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. YPSOMED AG
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. SCPHARMACEUTICALS, INC.
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. WILHELM HASELMEIER GMBH AND CO. KG
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. Insulet Corporation
2. BD
3. Enable Injections
4. Consort Medical plc
5. West Pharmaceutical Services, Inc
6. Elcam Medical
7. Amgen Inc
8. Ypsomed AG
9. scPharmaceuticals, Inc.
10. Wilhelm Haselmeier GmbH and Co. KG